Trial Profile
Efficacy of Methylphenidate for Management of Long-Term Attention Problems After Pediatric Traumatic Brain Injury (TBI)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2020
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 27 Jan 2020 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Mar 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.